Dimensionality of parkinsonian signs in aging and Alzheimer's disease.

BACKGROUND Parkinsonian signs are commonly found on the neurologic examination of older persons and are associated with morbidity and mortality. The extent to which parkinsonian signs in aging and Alzheimer's disease cluster in groups typical of Parkinson's disease has not been investigated previously. METHODS The motor portion of the Unified Parkinson's Disease Rating Scale (UPDRS), or a version with minor modifications, was administered to more than 2,800 persons in three cohorts: (a) 637 older persons with a wide range of neurologic conditions participating in the Chicago Health and Aging Project, a study of common health problems of a random sample of older persons from a geographically defined biracial community population; (b) 638 relatively healthy and highly educated older persons from 25 Catholic religious communities participating in the Religious Orders Study, a longitudinal clinical-pathologic study of aging; and (c) 1,546 older persons undergoing evaluation for possible dementia at the Rush Alzheimer's Disease Center, an urban, tertiary care center that evaluates persons for possible dementia. Separate factor analyses were performed on each data set. Additional analyses examined the factor structure in subsets by gender and race. RESULTS A similar grouping of items emerged in each cohort and did not differ substantially by gender or race. The factors corresponded closely with the traditional grouping of parkinsonian signs into bradykinesia, gait disturbance, rigidity, and tremor. CONCLUSIONS The grouping of parkinsonian signs is consistent in diverse samples of older persons and does not vary substantially across gender or race. The results provide an empirical basis for summarizing the principal motoric manifestations of parkinsonism.

[1]  J. Becker,et al.  Extrapyramidal signs in patients with probable Alzheimer disease. , 1997, Archives of neurology.

[2]  E D Louis,et al.  Mortality from Parkinson disease. , 1997, Archives of neurology.

[3]  F. Vingerhoets,et al.  Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? , 1997, Annals of neurology.

[4]  L. Waite,et al.  Neurological signs, aging, and the neurodegenerative syndromes. , 1996, Archives of neurology.

[5]  A Hofman,et al.  Prevalence of Parkinson's disease in the elderly , 1995, Neurology.

[6]  R. Mayeux,et al.  Subtle extrapyramidal signs and incident dementia , 1995, Neurology.

[7]  J. Kaye,et al.  Neurologic evaluation of the optimally healthy oldest old. , 1994, Archives of neurology.

[8]  Yaakov Stern,et al.  Relationships between extrapyramidal signs and cognitive function in a community‐dwelling cohort of patients with Parkinson's disease and normal elderly individuals , 1993, Annals of neurology.

[9]  M. Brin,et al.  Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. , 1993, The New England journal of medicine.

[10]  M. Finch,et al.  Predictors of cognitive and functional progression in patients with probable Alzheimer's disease , 1992, Neurology.

[11]  B. O’Donnell,et al.  The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course. , 1990, Archives of neurology.

[12]  L. Thal,et al.  Neurological findings in Alzheimer's disease and normal aging. , 1990, Archives of neurology.

[13]  J. Jankovic,et al.  The heterogeneity of Parkinson's disease , 1985, Neurology.

[14]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[15]  J. Hartigan Clustering Algorithms , 1975 .

[16]  M. Albert,et al.  Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer's disease. A community-based study. , 1993, Archives of neurology.

[17]  B. Snow,et al.  Criteria for diagnosing Parkinson's disease , 1992, Annals of neurology.

[18]  S. Fahn Unified Parkinson's Disease Rating Scale , 1987 .